Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Garrett, Christopher R."'
Publikováno v:
In Cancer Letters 10 April 2014 345(2):249-257
Autor:
Das, Prajnan, Eng, Cathy, Rodriguez-Bigas, Miguel A., Chang, George J., Skibber, John M., You, Y. Nancy, Maru, Dipen M., Munsell, Mark F., Clemons, Marilyn V., Kopetz, Scott E., Garrett, Christopher R., Shureiqi, Imad, Delclos, Marc E., Krishnan, Sunil, Crane, Christopher H.
Publikováno v:
In International Journal of Radiation Oncology, Biology, Physics 1 February 2014 88(2):301-305
Autor:
Tanasanvimon, Suebpong, Garg, Naveen, Viswanathan, Chitra, Truong, Mylene, Kaur, Harmeet, Kee, Bryan K., Sahin, Ibrahim H., Javle, Milind M., Garrett, Christopher R.
Publikováno v:
In Thrombosis Research February 2014 133(2):154-157
Autor:
Garrett, Christopher R., George, Ben, Viswanathan, Chitra, Bhadkamkar, Nishin A., Wen, Sijin, Baladandayuthapani, Veerarabhadran, You, Y. Nancy, Kopetz, Edmund S., Overman, Michael J., Kee, Bryan K., Eng, Cathy
Publikováno v:
In Clinical Colorectal Cancer September 2012 11(3):191-194
Autor:
Demetri, George D, van Oosterom, Allan T, Garrett, Christopher R, Blackstein, Martin E, Shah, Manisha H, Verweij, Jaap, McArthur, Grant, Judson, Ian R, Heinrich, Michael C, Morgan, Jeffrey A, Desai, Jayesh, Fletcher, Christopher D, George, Suzanne, Bello, Carlo L, Huang, Xin, Baum, Charles M, Casali, Paolo G
Publikováno v:
In The Lancet 2006 368(9544):1329-1338
Autor:
Garrett Christopher R, Javle Milind, Delclos Marc E, Krishnan Sunil, Crane Christopher H, Haque Waqar, Wolff Robert A, Das Prajnan
Publikováno v:
Radiation Oncology, Vol 4, Iss 1, p 55 (2009)
Abstract Background Reirradiation to the abdomen could potentially play a role in palliation of symptoms or local control in patients with gastrointestinal malignancies. Our goal was to retrospectively determine rates of toxicity, freedom from local
Externí odkaz:
https://doaj.org/article/f61485902fc9472f8ebccb1d392f72de
Autor:
Sahin, Ibrahim H.1, Garrett, Christopher R.1 cgarrett@mdanderson.org
Publikováno v:
Current Biomarker Findings. 2014, Vol. 4, p61-67. 7p.
Autor:
Das, Prajnan, Eng, Cathy, Rodriguez-Bigas, Miguel A., Chang, George J., Skibber, John M., You, Y. Nancy, Maru, Dipen M., Munsell, Mark F., Clemons, Marilyn V, Kopetz, Scott E., Garrett, Christopher R., Shureiqi, Imad, Delclos, Marc E., Krishnan, Sunil, Crane, Christopher H.
The goal of this phase 1 trial was to determine the maximum tolerated dose (MTD) of concurrent capecitabine, bevacizumab, and erlotinib with preoperative radiation therapy for rectal cancer.Patients with clinical stage II to III rectal adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::631db557f66a827c1ffd7a659130c631
https://europepmc.org/articles/PMC5592790/
https://europepmc.org/articles/PMC5592790/
Autor:
Al Omari, Amal, Abdelkhaleq, Hadeel, Al-Hussaini, Maysa, Turfa, Rim, Awad, Nour, Hassan, Manal M., Alfaqih, Mahmoud A., Garrett, Christopher R.
Publikováno v:
Journal of Global Oncology; 6/12/2018, Vol. 4, p1-10, 10p
Publikováno v:
International Journal of Surgical Oncology.
Patients with rectal cancers, due to the unique location of the tumor, have a recurrence pattern distinct from colon cancers. Advances in adjuvant therapy over the last three decades have played an important role in improving patient outcomes. This a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=hindawi_publ::9e448cca25e7952bc28c65c5bae49c76